Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Patient Monitoring

PUBLISHER: Grand View Research | PRODUCT CODE: 2067467

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2067467

Urea Breath Testing Market Size, Share & Trends Analysis Report By Test Location, By Application, By Patient Population, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Urea Breath Testing Market Summary

The global urea breath testing market size was valued at USD 374.13 million in 2025 and is projected to grow from USD 380.56 million in 2026 to USD 515.96 million by 2033, at a CAGR of 4.4% from 2026 to 2033. The North America urea breath testing industry held the largest share of 48.38% of the global market in 2025. The market growth is primarily driven by the rising global prevalence of Helicobacter pylori infections and associated gastrointestinal disorders, increasing preference for non-invasive and accurate gastrointestinal diagnostic technologies, and growing focus on gastric cancer prevention, early disease detection, and post-treatment monitoring. In addition, the expanding adoption of point-of-care diagnostic solutions, portable breath analyzers, and advanced 13C and 14C urea breath testing systems is further supporting global market expansion.

Global Urea Breath Testing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global urea breath testing market report based on test location, application, patient population, and region.

  • Test Location Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital-based Testing
  • Centralized Laboratories
  • Point-of-Care Testing (POCT)
  • Ambulatory Diagnostic Centers
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • H. pylori Initial Diagnosis
  • Post-treatment Confirmation
  • Peptic Ulcer Disease Evaluation
  • Gastritis Assessment
  • Dyspepsia Evaluation
  • Gastric Cancer Risk Monitoring
  • Patient Population Outlook (Revenue, USD Million, 2021 - 2033)
  • Adults
  • Pediatrics
  • Geriatric Population
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-928-3

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Test Location
    • 1.2.2. Application
    • 1.2.3. Patient Population
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Location Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. Patient Population Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urea Breath Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of Helicobacter pylori infections and gastrointestinal disorders
      • 3.2.1.2. Increasing preference for non-invasive and accurate gastrointestinal diagnostic technologies
      • 3.2.1.3. Growing focuses on gastric cancer prevention, early disease detection, and post-treatment monitoring
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Limited awareness and inadequate access to advanced diagnostic services in developing regions
      • 3.2.2.2. Availability of alternative diagnostic methods such as stool antigen tests, serology, endoscopy, and biopsy procedures
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Growing adoption of non-invasive and point-of-care gastrointestinal diagnostics
  • 3.3. Urea Breath Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Urea Breath Testing Market: Test Location Estimates & Trend Analysis

  • 4.1. Test Location Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Urea Breath Testing Market by Test Location Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. Hospital-based Testing
      • 4.4.1.1. Hospital-based Testing market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.2. Centralized Laboratories
      • 4.4.2.1. Centralized Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Point-of-Care Testing (POCT)
      • 4.4.3.1. Point-of-Care Testing (POCT) market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Ambulatory Diagnostic Centers
      • 4.4.4.1. Ambulatory Diagnostic Centers market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Urea Breath Testing Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Urea Breath Testing Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. H. pylori Initial Diagnosis
      • 5.4.1.1. H. pylori Initial Diagnosis market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.2. Post-treatment Confirmation
      • 5.4.2.1. Post-treatment Confirmation market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Peptic Ulcer Disease Evaluation
      • 5.4.3.1. Peptic Ulcer Disease Evaluation market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.4. Gastritis Assessment
      • 5.4.4.1. Gastritis Assessment market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.5. Dyspepsia Evaluation
      • 5.4.5.1. Dyspepsia Evaluation market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.6. Gastric Cancer Risk Monitoring
      • 5.4.6.1. Gastric Cancer Risk Monitoring market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Urea Breath Testing Market: Patient Population Estimates & Trend Analysis

  • 6.1. Patient Population Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Urea Breath Testing Market by Patient Population Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 6.4.1. Adults
      • 6.4.1.1. Adults market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.2. Pediatrics
      • 6.4.2.1. Pediatrics market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.4.3. Geriatric Population
      • 6.4.3.1. Geriatric Population market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Urea Breath Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033
  • 7.5. North America
    • 7.5.1. North America: SWOT Analysis
    • 7.5.2. U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe: SWOT Analysis
    • 7.6.2. UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.9. Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific: SWOT Analysis
    • 7.7.2. Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America: SWOT Analysis
    • 7.8.2. Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. MEA: SWOT Analysis
    • 7.9.2. South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Regulatory framework
      • 7.9.5.3. Competitive scenario
      • 7.9.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2025
    • 8.3.4. Thermo Fisher Scientific Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bio-Rad Laboratories Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Sercon Group
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Kibion GmbH
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. AdvaCare Pharma
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. AESKU.GROUP GmbH
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Kizlon Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Meridian Bioscience Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Paladin Pharma S.p.a.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Eurofins Scientific
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Beijing Richen-Force Science & Technology Co., Ltd
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Shenzhen Zhonghe Headway Bio-Sci & Tech Co. Ltd.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives
Show more
Product Code: GVR-4-68040-928-3

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 List of Secondary Sources
  • Table 3 Regulatory Framework
  • Table 4 Global Urea Breath Testing Market, By Region, 2021 - 2033 (USD Million)
  • Table 5 Global Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 6 Global Urea Breath Testing Market, By Application, 2021 - 2033 USD Million
  • Table 7 Global Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 8 North America Urea Breath Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 10 North America Urea Breath Testing Market, By Application, 2021 - 2033, USD Million
  • Table 11 North America Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 12 North America Urea Breath Testing Market, By Distribution Channel, 2021 - 2033, USD Million
  • Table 13 U.S. Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 14 U.S. Urea Breath Testing Market, By Application, 2021 - 2033, USD Million
  • Table 15 U.S. Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 16 Canada Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 17 Canada Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 18 Canada Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 19 Mexico Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 20 Mexico Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 21 Mexico Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 22 Europe Urea Breath Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 23 Europe Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 24 Europe Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 25 Europe Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 26 U.K. Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 27 U.K. Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 28 U.K. Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 29 Germany Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 30 Germany Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 31 Germany America Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 32 France Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 33 France Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 34 France Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 35 Spain Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 36 Spain Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 37 Spain Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 38 Italy Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 39 Italy Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 40 Italy Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 41 Asia Pacific Urea Breath Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 42 Asia Pacific Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 Asia-Pacific Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 45 China Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 46 China Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 47 China Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 48 Japan Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 49 Japan Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 50 Japan Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 51 India Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 52 India Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 53 India Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 54 South Korea Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 55 South Korea Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 56 South Korea Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 57 Australia Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 58 Australia Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 59 Australia Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 60 Latin America Urea Breath Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 61 Latin America Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 62 Latin America Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 63 Latin America Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 64 Brazil Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 65 Brazil Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Brazil Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 67 Argentina Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 68 Argentina Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 Argentina Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 70 MEA Urea Breath Testing Market, By Country, 2021 - 2033 (USD Million)
  • Table 71 MEA Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 72 MEA Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 73 MEA Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 74 South Africa Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 75 South Africa Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 76 South Africa Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 77 UAE Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 78 UAE Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 79 UAE Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 80 Saudi Arabia Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 81 Saudi Arabia Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)
  • Table 83 Kuwait Urea Breath Testing Market, By Test Location, 2021 - 2033 (USD Million)
  • Table 84 Kuwait Urea Breath Testing Market, By Application, 2021 - 2033 (USD Million)
  • Table 85 Kuwait Urea Breath Testing Market, By Patient Population, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Urea breath testing: market outlook
  • Fig. 14 Urea breath testing competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Urea breath testing driver impact
  • Fig. 20 Urea breath testing restraint impact
  • Fig. 21 Urea breath testing strategic initiatives analysis
  • Fig. 22 Urea breath testing: test location movement analysis
  • Fig. 23 Urea breath testing: test location outlook and key takeaways
  • Fig. 24 Hospital-based testing market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Centralized laboratories market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Point-of-care testing (POCT) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Ambulatory diagnostic centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Urea breath testing: application movement analysis
  • Fig. 29 Urea breath testing: application outlook and key takeaways
  • Fig. 30 H. pylori initial diagnosis market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Post-treatment confirmation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Peptic ulcer disease evaluation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Gastritis assessment market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Dyspepsia evaluation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Gastric cancer risk monitoring market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Urea breath testing: patient population movement analysis
  • Fig. 37 Urea breath testing: patient population outlook and key takeaways
  • Fig. 38 Adults market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Pediatrics market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Geriatric population market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Global urea breath testing market: Regional movement analysis
  • Fig. 42 Global urea breath testing market: Regional outlook and key takeaways
  • Fig. 43 Global urea breath testing market shares and leading players
  • Fig. 44 North America
  • Fig. 45 North America market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 U.S.
  • Fig. 47 U.S. market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Canada
  • Fig. 49 Canada market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico
  • Fig. 51 Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Europe
  • Fig. 53 Europe market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 54 UK
  • Fig. 55 UK market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Germany
  • Fig. 57 Germany market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 France
  • Fig. 59 France market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Italy
  • Fig. 61 Italy market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Spain
  • Fig. 63 Spain market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Denmark
  • Fig. 65 Denmark market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Sweden
  • Fig. 67 Sweden market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Norway
  • Fig. 69 Norway market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Asia Pacific
  • Fig. 71 Asia Pacific market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 China
  • Fig. 73 China market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Japan
  • Fig. 75 Japan market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 76 India
  • Fig. 77 India market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 78 Thailand
  • Fig. 79 Thailand market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 South Korea
  • Fig. 81 South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 82 Australia
  • Fig. 83 Australia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 84 Latin America
  • Fig. 85 Latin America market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 86 Brazil
  • Fig. 87 Brazil market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 88 Argentina
  • Fig. 89 Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 90 Middle East and Africa
  • Fig. 91 Middle East and Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 92 South Africa
  • Fig. 93 South Africa market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 94 Saudi Arabia
  • Fig. 95 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 96 UAE
  • Fig. 97 UAE market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 98 Kuwait
  • Fig. 99 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 100 Market share of key market players- Urea Breath Testing
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!